Integrating Social Determinants of Health and Laboratory Data: A Pilot Study To Evaluate Co-Use of Opioids and Benzodiazepines
As the opioid crisis continues to have devastating consequences for our communities, families, and patients, innovative approaches are necessary to augment clinical care and the management of patients with opioid use disorders. As stewards of health analytic data, laboratories are uniquely poised to...
Main Authors: | Jill S. Warrington MD, PhD, Nick Lovejoy BS, MPH, Jamie Brandon BA, Keith Lavoie BS, Chris Powell BA |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-10-01
|
Series: | Academic Pathology |
Online Access: | https://doi.org/10.1177/2374289519884877 |
Similar Items
-
Anticonvulsant Effects of Aerial Parts of Extract in Mice: Involvement of Benzodiazepine and Opioid Receptors
by: Amir Rashidian PharmD, PhD, et al.
Published: (2017-10-01) -
A comparison of opioids and benzodiazepines dispensing in Australia.
by: M Mofizul Islam, et al.
Published: (2019-01-01) -
Driving Access to Care: Use of Mobile Units for Urine Specimen Collection During the Coronavirus Disease-19 (COVID-19) Pandemic
by: Jill S. Warrington MD, PhD, et al.
Published: (2020-09-01) -
Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses
by: Zin CS, et al.
Published: (2017-01-01) -
Reduction in the use of benzodiazepines and cyclopyrrolones in general practice
by: Jørgensen VR, et al.
Published: (2008-09-01)